AIMT - Aimmune Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

with an average price target of $17.45. This is a potential upside of $17.45 (0%) from yesterday's end of day stock price of $0.

Aimmune Therapeutics's activity chart (see below) currently has 134 price targets and 96 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 35.02% with an average time for these price targets to be met of 113.21 days.

Most recent stock forecast was given by DEREK ARCHILA from WELLS FARGO on 31-Aug-2020. First documented stock forecast 30-Aug-2015.

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold

$18

5 years 1 months 24 days ago
(31-Aug-2020)

3/3 (100%)

$3.19 (21.54%)

78

Hold

$60

5 years 1 months 24 days ago
(30-Aug-2020)

0/19 (0%)

$41.31 (221.03%)

Hold

$34.5

$0.01 (0.03%)

$66

5 years 1 months 24 days ago
(30-Aug-2020)

1/8 (12.5%)

$0.28 (0.82%)

39

Hold

$34.5

$0.01 (0.03%)

$14

5 years 1 months 24 days ago
(30-Aug-2020)

7/7 (100%)

$0.28 (0.82%)

105

Hold

$35

$0.51 (1.48%)

$24

5 years 1 months 24 days ago
(30-Aug-2020)

7/17 (41.18%)

$0.78 (2.28%)

376

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is AIMT (Aimmune Therapeutics) average time for price targets to be met?

On average it took 113.21 days on average for the stock forecasts to be realized with a an average price target met ratio 35.02

Which analyst has the current highest performing score on AIMT (Aimmune Therapeutics) with a proven track record?

CHARLES DUNCAN

Which analyst has the most public recommendations on AIMT (Aimmune Therapeutics)?

Charles Duncan has 14 price targets and 8 ratings on AIMT

Which analyst is the currently most bullish on AIMT (Aimmune Therapeutics)?

Jotin Marango with highest potential upside - $45.51

Which analyst is the currently most reserved on AIMT (Aimmune Therapeutics)?

Andrew Fein with lowest potential downside - -$19.49

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?